November 9-11, 2020 | Virtual Conference

CONNECT
+ SHARE

This year – wherever you’re located – you can be part of the only online experience for generics and biosimilars professionals

AN ONLINE EXPERIENCE FOR GENERIC AND BIOSIMILAR MEDICINES PROFESSIONALS

GRx+Biosims 2020
is going virtual

The mission of providing America’s patients with access to the generic and biosimilar medicines they need remains our top priority. As this country faces the challenges of COVID-19, the importance of our mission comes into clearer focus – and the need to share knowledge and best practices has even greater urgency.

Due to public health and safety concerns related to the coronavirus (COVID-19) pandemic, we decided to web-stream the conference. The format may be new but will still allow you to participate in Q&A with speakers, engage with your peers and meet with exhibitors.

View Justification Toolkit

Conference Imagery

Connecting to learn + share solutions for the future

GRx+Biosims 2020 is the premier scientific and regulatory event for the U.S. generics and biosimilars industries, featuring timely programming relevant to technical, regulatory and policy professionals.

Top officials and subject-matter experts share their knowledge and best practices to enhance attendees’ understanding of how to succeed in generic and biosimilar development; the regulatory process and approvals: and the evolving policy landscape.

Speaker Highlights

The keynote speakers committed to GRx+Biosims 2020 are among our nation’s leading health regulators and authorities. We have confirmed Office of Generic Drug Director Sally Choe, PhD, and Office of Therapeutic Biologics and Biosimilars Director Sarah Yim, M.D., and have invited FDA Commissioner Stephen Hahn, M.D., and CMS Administrator Seema Verma to address the industry.

Sarah Yim, M.D.

Director
Office of Therapeutic Biologics and Biosimilars, CDER’s Office of New Drugs (OND), FDA

Gerald Dal Pan, M.D., MHS

Director
Office of Surveillance and Epidemiology, CDER, FDA

Sally Choe, PhD

Director
Office of Generic Drugs (OGD), CDER, FDA

Donald D. Ashley, JD

Director
Office of Compliance, CDER, FDA

Why You Should Attend

We’ve made it easier now than ever before to be able to attend the conference. No matter where you are physically on November 9-11, you will be able to attend and access all sessions.

Register Today

Attending the GRx+Biosims 2020 conference?

Networking is a big part of this event, and we’ve got all kinds of ready-to-use, simple-to-customize and easy-to-share content that will help you jumpstart your networking efforts.

Virtual Conference FAQs 

Our meetings team is hard at work from home, putting together a fantastic event that will deliver an outstanding virtual conference experience.  Please use our list of FAQs to find answers to your immediate questions.

Learn More

Our Sponsors

PLATINUM SPONSOR

PUBLICATION PARTNERS

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Skip to content